OptiBiotix Health (LON:OPTI) Stock Price Down 1.7% – What’s Next?

OptiBiotix Health Plc (LON:OPTI)’s stock price fell 1.7% during mid-day trading on Thursday. The stock traded as low as GBX 5.80 and last traded at GBX 5.80. Approximately 193,493 shares traded hands during trading, a decline of 43% from the average session volume of 338,455 shares. The stock had previously closed at GBX 5.90.

OptiBiotix Health Price Performance

The stock has a fifty day moving average price of GBX 5.81 and a 200-day moving average price of GBX 5.72. The company has a market cap of £5.99 million, a PE ratio of -1.38 and a beta of 1.82.

OptiBiotix Health (LON:OPTI) last issued its quarterly earnings results on Thursday, September 17th. The company reported GBX (1.52) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.